{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:25:05Z","timestamp":1790277905846,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Fondation pour le recherche m\u00e9dicale","award":["DQ20170336751"],"award-info":[{"award-number":["DQ20170336751"]}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-18-RHUS-0012-BETPSY project"],"award-info":[{"award-number":["ANR-18-RHUS-0012-BETPSY project"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011963","name":"European Academy of Neurology","doi-asserted-by":"publisher","award":["Clinical Fellowship 2017"],"award-info":[{"award-number":["Clinical Fellowship 2017"]}],"id":[{"id":"10.13039\/501100011963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12311-020-01159-x","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T11:04:18Z","timestamp":1593169458000},"page":"715-721","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies"],"prefix":"10.1007","volume":"19","author":[{"given":"Sergio","family":"Mu\u00f1iz-Castrillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Vogrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastien","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laurie","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Chaumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Rogemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fabien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4721-5952","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Honnorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"1159_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/archneur.58.2.225","volume":"58","author":"J Honnorat","year":"2001","unstructured":"Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, et al. Cerebellar ataxia with anti\u2013glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol. 2001;58:225\u201330.","journal-title":"Arch Neurol"},{"key":"1159_CR2","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1093\/brain\/awn183","volume":"131","author":"A Saiz","year":"2008","unstructured":"Saiz A, Blanco Y, Sabater L, Gonz\u00e1lez F, Bataller L, Casamitjana R, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain. 2008;131:2553\u201363.","journal-title":"Brain."},{"key":"1159_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1684\/epd.2013.0607","volume":"15","author":"ME Garc\u00eda Garc\u00eda","year":"2013","unstructured":"Garc\u00eda Garc\u00eda ME, Castrillo SM, Morales IG, Sacoto DDC, Dolado AM. Acute amnesia and seizures in a young female. Epileptic Disord. 2013;15:455\u201360.","journal-title":"Epileptic Disord"},{"key":"1159_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40673-015-0034-y","volume":"2","author":"H Mitoma","year":"2015","unstructured":"Mitoma H, Hadjivassiliou M, Honnorat J. Guidelines for treatment of immune-mediated cerebellar ataxias. Cerebellum Ataxias. 2015;2:14.","journal-title":"Cerebellum Ataxias"},{"key":"1159_CR5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/jamaneurol.2014.1011","volume":"71","author":"H Ari\u00f1o","year":"2014","unstructured":"Ari\u00f1o H, Gresa-Arribas N, Blanco Y, Mart\u00ednez-Hern\u00e1ndez E, Sabater L, Petit-Pedrol M, et al. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy. JAMA Neurol. 2014;71:1009\u201316.","journal-title":"JAMA Neurol"},{"key":"1159_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/jnnp.73.3.345","volume":"73","author":"S Matsumoto","year":"2002","unstructured":"Matsumoto S. Acute attacks and brain stem signs in a patient with glutamic acid decarboxylase autoantibodies. J Neurol Neurosurg Psychiatry. 2002;73:345\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1159_CR7","doi-asserted-by":"crossref","unstructured":"Gresa-Arribas N, Ari\u00f1o H, Mart\u00ednez-Hern\u00e1ndez E, Petit-Pedrol M, Sabater L, Saiz A, et al. Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity. Ruprecht K, editor. PLOS ONE. 2015;10:e0121364.","DOI":"10.1371\/journal.pone.0121364"},{"key":"1159_CR8","doi-asserted-by":"publisher","unstructured":"Mu\u00f1iz-Castrillo S, Ambati A, Dubois V, Vogrig A, Joubert B, Rogemond V, et al. Primary DQ effect in the association between HLA and neurological syndromes with anti-GAD65 antibodies. J Neurol. 2020. https:\/\/doi.org\/10.1007\/s00415-020-09782-8.","DOI":"10.1007\/s00415-020-09782-8"},{"key":"1159_CR9","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1001\/archneur.61.6.902","volume":"61","author":"G Rakocevic","year":"2004","unstructured":"Rakocevic G, Raju R, Dalakas MC. Anti\u2013glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity. Arch Neurol. 2004;61:902\u20134.","journal-title":"Arch Neurol"},{"key":"1159_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1750-1172-6-3","volume":"6","author":"MU Manto","year":"2011","unstructured":"Manto MU, Hampe CS, Rogemond V, Honnorat J. Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia. Orphanet J Rare Dis. 2011;6:3.","journal-title":"Orphanet J Rare Dis"},{"key":"1159_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/jnnp.70.3.386","volume":"70","author":"H Takenoshita","year":"2001","unstructured":"Takenoshita H, Shizuka-Ikeda M, Mitoma H, Song S, Harigaya Y, Igeta Y, et al. Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia. J Neurol Neurosurg Psychiatry. 2001;70:386\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1159_CR12","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1001\/archneur.62.8.1300","volume":"62","author":"C Tilikete","year":"2005","unstructured":"Tilikete C, Vighetto A, Trouillas P, Honnorat J. Anti-GAD antibodies and periodic alternating Nystagmus. Arch Neurol. 2005;62:1300\u20133.","journal-title":"Arch Neurol"},{"key":"1159_CR13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ana.21123","volume":"61","author":"M-U Manto","year":"2007","unstructured":"Manto M-U, Laute M-A, Aguera M, Rogemond V, Pandolfo M, Honnorat J. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases: GAD-Ab and cerebellar function. Ann Neurol. 2007;61:544\u201351.","journal-title":"Ann Neurol"},{"key":"1159_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jns.2009.12.006","volume":"290","author":"G Piccolo","year":"2010","unstructured":"Piccolo G, Tavazzi E, Cavallaro T, Romani A, Scelsi R, Martino G. Clinico-pathological findings in a patient with progressive cerebellar ataxia, autoimmune polyendocrine syndrome, hepatocellular carcinoma and anti-GAD autoantibodies. J Neurol Sci. 2010;290:148\u20139.","journal-title":"J Neurol Sci"},{"key":"1159_CR15","doi-asserted-by":"crossref","unstructured":"Dalmau J, Gonzalez RG, Lerwill MF. Case 4-2007: a 56-year-old woman with rapidly progressive Vertigo and Ataxia. Cabot RC, Harris NL, Shepard J-AO, Rosenberg ES, Cort AM, Ebeling SH, et al., editors. N Engl J Med 2007;356:612\u2013620.","DOI":"10.1056\/NEJMcpc069035"},{"key":"1159_CR16","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s10072-011-0648-7","volume":"32","author":"E Ogawa","year":"2011","unstructured":"Ogawa E, Sakakibara R, Kawashima K, Yoshida T, Kishi M, Tateno F, et al. VGCC antibody-positive paraneoplastic cerebellar degeneration presenting with positioning vertigo. Neurol Sci. 2011;32:1209\u201312.","journal-title":"Neurol Sci"},{"key":"1159_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1056\/NEJMoa1816721","volume":"381","author":"C Mandel-Brehm","year":"2019","unstructured":"Mandel-Brehm C, Dubey D, Kryzer TJ, O\u2019Donovan BD, Tran B, Vazquez SE, et al. Kelch-like protein 11 antibodies in seminoma-associated paraneoplastic encephalitis. N Engl J Med. 2019;381:47\u201354.","journal-title":"N Engl J Med"},{"key":"1159_CR18","first-page":"32","volume":"38","author":"AI Martins","year":"2018","unstructured":"Martins AI, Carvalho JN, Amorim AM, Geraldo A, Eggenberger E, Lemos J. Disabling Central Paroxysmal Positioning Upbeat Nystagmus and Vertigo Associated With the Presence of Anti\u2013Glutamic Acid Decarboxylase Antibodies: J Neuroophthalmol. 2018;38:32\u20135.","journal-title":"Disabling Central Paroxysmal Positioning Upbeat Nystagmus and Vertigo Associated With the Presence of Anti\u2013Glutamic Acid Decarboxylase Antibodies: J Neuroophthalmol"},{"key":"1159_CR19","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1196\/annals.1325.042","volume":"1039","author":"C Tilikete","year":"2005","unstructured":"Tilikete C, Vighetto A, Trouillas P, Honnorat J. Potential role of anti-GAD antibodies in abnormal eye movements. Ann N Y Acad Sci. 2005;1039:446\u201354.","journal-title":"Ann N Y Acad Sci"},{"key":"1159_CR20","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1093\/brain\/aww225","volume":"139","author":"LM Yshii","year":"2016","unstructured":"Yshii LM, Gebauer CM, Pignolet B, Maur\u00e9 E, Qu\u00e9riault C, Pierau M, et al. CTLA4 blockade elicits paraneoplastic neurological disease in a mouse model. Brain. 2016;139:2923\u201334.","journal-title":"Brain."},{"key":"1159_CR21","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s12311-019-01075-9","volume":"18","author":"A Vogrig","year":"2019","unstructured":"Vogrig A, Bernardini A, Gigli GL, Corazza E, Marini A, Segatti S, et al. Stroke-like presentation of paraneoplastic cerebellar degeneration: a single-center experience and review of the literature. Cerebellum. 2019;18:976\u201382.","journal-title":"Cerebellum"},{"key":"1159_CR22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/ana.21450","volume":"64","author":"M Hadjivassiliou","year":"2008","unstructured":"Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol. 2008;64:332\u201343.","journal-title":"Ann Neurol"},{"key":"1159_CR23","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1212\/WNL.0b013e3182919070","volume":"80","author":"M Hadjivassiliou","year":"2013","unstructured":"Hadjivassiliou M, Aeschlimann P, Sanders DS, M\u00e4ki M, Kaukinen K, Gr\u00fcnewald RA, et al. Transglutaminase 6 antibodies in the diagnosis of gluten ataxia. Neurology. 2013;80:1740\u20135.","journal-title":"Neurology."},{"key":"1159_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1600-0404.2010.01356.x","volume":"123","author":"M Hadjivassiliou","year":"2011","unstructured":"Hadjivassiliou M, Aeschlimann D, Gr\u00fcnewald RA, Sanders DS, Sharrack B, Woodroofe N. GAD antibody-associated neurological illness and its relationship to gluten sensitivity. Acta Neurol Scand. 2011;123:175\u201380.","journal-title":"Acta Neurol Scand"},{"key":"1159_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s12311-015-0664-x","volume":"15","author":"H Mitoma","year":"2016","unstructured":"Mitoma H, Adhikari K, Aeschlimann D, Chattopadhyay P, Hadjivassiliou M, Hampe CS, et al. Consensus paper: neuroimmune mechanisms of cerebellar ataxias. Cerebellum. 2016;15:213\u201332.","journal-title":"Cerebellum"},{"key":"1159_CR26","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1136\/jnnp.2004.049809","volume":"76","author":"ID Wilkinson","year":"2005","unstructured":"Wilkinson ID, Hadjivassiliou M, Dickson JM, Wallis L, Gr\u00fcnewald RA, Coley SC, et al. Cerebellar abnormalities on proton MR spectroscopy in gluten ataxia. J Neurol Neurosurg Psychiatry. 2005;76:1011\u20133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1159_CR27","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.neurad.2012.08.003","volume":"40","author":"M Hadjivassiliou","year":"2013","unstructured":"Hadjivassiliou M, Currie S, Hoggard N. MR spectroscopy in paraneoplastic cerebellar degeneration. J Neuroradiol J Neuroradiol. 2013;40:310\u20132.","journal-title":"J Neuroradiol J Neuroradiol"},{"key":"1159_CR28","doi-asserted-by":"crossref","unstructured":"Hadjivassiliou M, Graus F, Honnorat J, Jarius S, Titulaer M, Manto M, et al. Diagnostic Criteria for Primary Autoimmune Cerebellar Ataxia-Guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias. Cerebellum Lond Engl. 2020;","DOI":"10.1007\/s12311-020-01132-8"},{"key":"1159_CR29","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000371","volume":"4","author":"B Joubert","year":"2017","unstructured":"Joubert B, Gobert F, Thomas L, Saint-Martin M, Desestret V, Convers P, et al. Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis. Neurol - Neuroimmunol Neuroinflammation. 2017;4:e371.","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"key":"1159_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/B978-0-444-64189-2.00013-5","volume":"155","author":"JC Jen","year":"2018","unstructured":"Jen JC, Wan J. Episodic ataxias. Handb Clin Neurol. 2018;155:205\u201315.","journal-title":"Handb Clin Neurol"}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-020-01159-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-020-01159-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-020-01159-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T23:42:35Z","timestamp":1624664555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-020-01159-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1159"],"URL":"https:\/\/doi.org\/10.1007\/s12311-020-01159-x","relation":{},"ISSN":["1473-4222","1473-4230"],"issn-type":[{"value":"1473-4222","type":"print"},{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"assertion":[{"value":"26 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='' removed-->Conflict of Interest"}},{"value":"This study followed the Declaration of Helsinki and was performed according to the guidelines of the Institutional Review Board of the Universit\u00e9 Claude Bernard Lyon 1 and Hospices Civils de Lyon.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}